| Literature DB >> 22778835 |
Abstract
The new mixed dopamaine D(2)/serotonin 5-HT(2A) antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.Entities:
Mesh：
Substances：
Year: 2010 PMID： 22778835 PMCID： PMC3368683 DOI： 10.1021/cn100024g
Source DB: PubMed Journal: ACS Chem Neurosci ISSN： 1948-7193 Impact factor: 4.418